{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:35:08Z","timestamp":1793392508517,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.psychres.2022.114911","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T02:58:58Z","timestamp":1665802738000},"page":"114911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Ketamine use in pediatric depression: A systematic review"],"prefix":"10.1016","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7010-1785","authenticated-orcid":false,"given":"Shakila","family":"Meshkat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-4493","authenticated-orcid":false,"given":"Roger C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-3361","authenticated-orcid":false,"given":"Taeho Greg","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6815-7248","authenticated-orcid":false,"given":"Felicia","family":"Ceban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3764-9677","authenticated-orcid":false,"given":"Kevork","family":"Danayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-5854","authenticated-orcid":false,"given":"Noah","family":"Chisamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.Di","family":"Vincenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2022.114911_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111928","article-title":"Long-lasting effects of repeated ketamine administration in adult and adolescent rats","volume":"369","author":"Bates","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2022.114911_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114579","article-title":"Sex differences in ketamine's therapeutic effects for mood disorders: a systematic review","volume":"312","author":"Benitah","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2022.114911_bib0003","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/ALN.0b013e318242b2cd","article-title":"Ketamine-inducedneuroapoptosis in the fetal and neonatal rhesus macaque brain","volume":"116","author":"Brambrink","year":"2012","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.psychres.2022.114911_bib0004","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-021-00846-5","article-title":"Prevention and management of common adverse effects of ketamine and esketamine in patients with mood disorders","volume":"35","author":"Ceban","year":"2021","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.psychres.2022.114911_bib0005","first-page":"442","article-title":"Treatment of childhood and adolescent depression","volume":"86","author":"Clark","year":"2012","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.psychres.2022.114911_bib0006","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2147\/DDDT.S221437","article-title":"Ketamine and depression: a narrative review","volume":"13","author":"Corriger","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.psychres.2022.114911_bib0007","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/2013.jamapsychiatry.24","article-title":"Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder","volume":"70","author":"Croarkin","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2022.114911_bib0008","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/cap.2018.0030","article-title":"Intravenous ketamine for adolescents with treatment-resistant depression: an open-label study","volume":"28","author":"Cullen","year":"2018","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2022.114911_bib0009","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1037\/a0034733","article-title":"Comorbidity of anxiety and depression in children and adolescents: 20 years after","volume":"140","author":"Cummings","year":"2014","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.psychres.2022.114911_bib0010","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/da.22709","article-title":"Anhedonia is associated with suicidal ideation independently of depression: a meta-analysis","volume":"35","author":"Ducasse","year":"2018","journal-title":"Depress. Anxiety"},{"issue":"4","key":"10.1016\/j.psychres.2022.114911_bib0011","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaac.2017.01.006","article-title":"Ketamine as a treatment for adolescent depression: a case report","volume":"56","author":"Dwyer","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114911_bib0012","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1176\/appi.focus.22020004","article-title":"Efficacy of intravenous ketamine in adolescent treatment-resistant depression: a randomized midazolam-controlled trial","volume":"20","author":"Dwyer","year":"2022","journal-title":"Focus"},{"key":"10.1016\/j.psychres.2022.114911_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114321","article-title":"Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: results from the canadian rapid treatment center of excellence","volume":"307","author":"Di Vincenzo","year":"2022","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.psychres.2022.114911_bib0014","doi-asserted-by":"crossref","first-page":"e694","DOI":"10.1542\/peds.2014-4152","article-title":"Remission from behavioral dysregulation in a child with PTSD after receiving procedural ketamine","volume":"136","author":"Donoghue","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.psychres.2022.114911_bib0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1192\/bjp.188.3.216","article-title":"Longitudinal investigation into childhood and adolescence-onset depression: psychiatric outcome in early adulthood","volume":"188","author":"Dunn","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114911_bib0016","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jpeds.2018.09.021","article-title":"Prevalence and treatment of depression, anxiety, and conduct problems in US children","volume":"206","author":"Ghandour","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.psychres.2022.114911_bib0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","article-title":"The economic burden of adults with major depressive disorder in the United States (2005 and 2010)","volume":"76","author":"Greenberg","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2022.114911_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-66784-2","article-title":"Validating a functional near-infrared spectroscopy diagnostic paradigm for major depressive disorder","volume":"10","author":"Husain","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2022.114911_bib0019","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/01.chi.0000242228.75516.21","article-title":"Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS)","volume":"45","author":"Kennard","year":"2006","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2022.114911_bib0020","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuron.2019.02.005","article-title":"Ketamine: a paradigm shift for depression research and treatment","volume":"101","author":"Krystal","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2022.114911_bib0021","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/0269881114568041","article-title":"Neural correlates of change in major depressive disorder anhedonia following open-label ketamine","volume":"29","author":"Lally","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2022.114911_bib0022","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jad.2020.06.050","article-title":"The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis","volume":"276","author":"McIntyre","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.psychres.2022.114911_bib0023","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114911_bib0024","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpsychires.2021.11.036","article-title":"Pharmacogenomics of ketamine: a systematic review","volume":"145","author":"Meshkat","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"10","key":"10.1016\/j.psychres.2022.114911_bib0025","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"APA council of research task force on novel biomarkers and treatments. Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114911_bib0026","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jad.2021.06.032","article-title":"Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: a systematic review","volume":"293","author":"Ng","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2022.114911_bib0027","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0269881106069938","article-title":"The other face of depression, reduced positive affect: the role of catecholamines in causation and cure","volume":"21","author":"Nutt","year":"2007","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2022.114911_bib0028","first-page":"e1","article-title":"Efficacy of ketamine in pediatric sedation dentistry: a systematic review","volume":"39","author":"Oh","year":"2018","journal-title":"Compend. Contin. Educ. Dent."},{"key":"10.1016\/j.psychres.2022.114911_bib0029","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jchemneu.2018.12.002","article-title":"Subchronic ketamine alters behaviour, metabolic indices and brain morphology in adolescent rats: involvement of oxidative stress, glutamate toxicity and caspase-3-mediated apoptosis","volume":"96","author":"Onaolapo","year":"2019","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.psychres.2022.114911_bib0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2022.114911_bib0031","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jad.2017.08.081","article-title":"Clinical experience using intranasal ketamine in the longitudinal treatment of juvenile bipolar disorder with fear of harm phenotype","volume":"225","author":"Papolos","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"1\u20133","key":"10.1016\/j.psychres.2022.114911_bib0032","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jad.2012.08.040","article-title":"Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder\/fear of harm phenotype","volume":"147","author":"Papolos","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.psychres.2022.114911_bib0033","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.biopsych.2013.04.027","article-title":"Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats","volume":"74","author":"Parise","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114911_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112367","article-title":"Antidepressant effects of ketamine on depression-related phenotypes and dopamine dysfunction in rodent models of stress","volume":"379","author":"Rinc\u00f3n-Cort\u00e9s","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"8","key":"10.1016\/j.psychres.2022.114911_bib0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/14740338.2020.1776699","article-title":"Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence","volume":"19","author":"Rodrigues","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.psychres.2022.114911_bib0036","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0269881120928203","article-title":"Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: preliminary evidence in adolescents with treatment-resistant depression","volume":"35","author":"Roy","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2022.114911_bib0037","doi-asserted-by":"crossref","first-page":"13514","DOI":"10.4088\/JCP.18r12475","article-title":"Oral ketamine for depression: a systematic review","volume":"80","author":"Rosenblat","year":"2019","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2022.114911_bib0038","doi-asserted-by":"crossref","first-page":"e99855","DOI":"10.1371\/journal.pone.0099855","article-title":"Impact of ketamine on learning and memory function, neuronal apoptosis and its potential association with miR-214 and PTEN in adolescent rats","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2022.114911_bib0039","first-page":"9375910","article-title":"Case report of subanesthetic intravenous ketamine infusion for the treatment of neuropathic pain and depression with suicidal features in a pediatric patient","author":"Weber","year":"2018","journal-title":"Case Rep. Anesthesiol."},{"key":"10.1016\/j.psychres.2022.114911_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112342","article-title":"Ketamine reverses the impaired fear memory extinction and accompanied depressive-like behaviors in adolescent mice","volume":"379","author":"Wei","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2022.114911_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.704330","article-title":"Antianhedonic effect of repeated ketamine infusions in patients with treatment resistant depression","volume":"12","author":"Wilkowska","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114911_bib0042","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychires.2020.12.038","article-title":"The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: a systematic review and meta-analysis","volume":"134","author":"Xiong","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2022.114911_bib0043","first-page":"201","article-title":"Effects of low-dose and very low-dose ketamine among patientswith major depression: a systematic review and meta-analysis","volume":"19","author":"Xu","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2022.114911_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12910-016-0087-3","article-title":"Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications","volume":"17","author":"Zhang","year":"2016","journal-title":"BMC Med. Ethics"},{"issue":"6","key":"10.1016\/j.psychres.2022.114911_bib0045","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/cap.2019.0028","article-title":"Successful use of ketamine for the treatment of psychotic depression in a teenager","volume":"29","author":"Zarrinnegar","year":"2019","journal-title":"J. Child Adolesc. Psychopharmacol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122005029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122005029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:05:23Z","timestamp":1759039523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178122005029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":45,"alternative-id":["S0165178122005029"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114911","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine use in pediatric depression: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114911"}}